Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Int J Clin Pract. 2021 Oct;75(10):e14655. doi: 10.1111/ijcp.14655. Epub 2021 Aug 3.
Cardiogenic shock (CS) is the most severe complication after acute myocardial infarction (AMI) with mortality above 50%. Inflammatory response is involved in the pathology of CS and AMI. In this study, we aimed to evaluate the prognostic value of admission neutrophil-lymphocyte ratio (NLR) in patients with CS complicating AMI.
Two hundred and seventeen consecutive patients with CS after AMI were divided into two groups according to the admission NLR cut-off value ≤7.3 and >7.3. The primary outcome was 30-day all-cause mortality and the secondary end-point was the composite events of major adverse cardiovascular events (MACE), including all-cause mortality, ventricular tachycardia/ventricular fibrillation, atrioventricular block, gastrointestinal haemorrhage and non-fatal stroke. Cox proportional hazard models were performed to analyse the association of NLR with the outcome. NLR cut-off value was determined by Youden index.
Patients with NLR > 7.3 were older and presented with lower lymphocyte count, higher admission heart rate, B-type natriuretic peptide, leucocyte, neutrophil and creatinine (all P < .05). During a period of 30-day follow-up after admission, mortality in patients with NLR > 7.3 was significantly higher than in patients with NLR ≤ 7.3 (73.7% vs. 26.3%, P < .001). The incidence of MACE was also remarkably higher in patients with NLR > 7.3 (87.9% vs. 53.4%, P < .001). After multivariable adjustment, NLR > 7.3 remained an independent predictor for higher risk of 30-day mortality (HR 2.806; 95%CI 1.784, 4.415, P < .001) and MACE (HR 2.545; 95%CI 1.791, 3.617, P < .001).
Admission NLR could be used as an important tool for short-term prognostic evaluation in patients with CS complicating AMI and higher NLR is an independent predictor for increased 30-day all-cause mortality and MACE.
心原性休克(CS)是急性心肌梗死(AMI)后最严重的并发症,死亡率超过 50%。炎症反应与 CS 和 AMI 的病理有关。在这项研究中,我们旨在评估入院时中性粒细胞与淋巴细胞比值(NLR)在 CS 合并 AMI 患者中的预后价值。
根据入院时 NLR 截断值≤7.3 和>7.3,将 217 例连续 CS 合并 AMI 患者分为两组。主要终点为 30 天全因死亡率,次要终点为主要不良心血管事件(MACE)的复合终点,包括全因死亡率、室性心动过速/心室颤动、房室传导阻滞、胃肠道出血和非致命性卒中。采用 Cox 比例风险模型分析 NLR 与结局的关系。通过 Youden 指数确定 NLR 截断值。
NLR>7.3 的患者年龄较大,淋巴细胞计数较低,入院时心率、B 型利钠肽、白细胞、中性粒细胞和肌酐较高(均 P<.05)。在入院后 30 天的随访期间,NLR>7.3 的患者死亡率明显高于 NLR≤7.3 的患者(73.7% vs. 26.3%,P<.001)。NLR>7.3 的患者 MACE 发生率也显著较高(87.9% vs. 53.4%,P<.001)。多变量调整后,NLR>7.3 仍然是 30 天死亡率(HR 2.806;95%CI 1.784,4.415,P<.001)和 MACE(HR 2.545;95%CI 1.791,3.617,P<.001)的独立预测因子。
入院时 NLR 可作为 CS 合并 AMI 患者短期预后评估的重要工具,较高的 NLR 是 30 天全因死亡率和 MACE 增加的独立预测因子。